(-0.63%) 4 979.40 points
(0.51%) 37 969 points
(-1.57%) 15 357 points
(0.83%) $83.42
(-0.06%) $1.756
(0.47%) $2 409.20
(1.34%) $28.76
(-1.14%) $943.60
(-0.06%) $0.939
(-0.15%) $11.03
(0.54%) $0.808
(-0.95%) $93.01
0.00% $ 0.0000010
Live Chart Being Loaded With Signals
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage...
Stats | |
---|---|
Today's Volume | 500.00 |
Average Volume | 0.00 |
Market Cap | 20 014.00 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Volume Correlation
Pathfinder Cell Therapy, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pathfinder Cell Therapy, Correlation - Currency/Commodity
Pathfinder Cell Therapy, Financials
Annual | 2014 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.00209 |
Q3 | 2015 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.000433 |
Q2 | 2015 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.000333 |
Q1 | 2015 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.000414 |
Financial Reports:
No articles found.
Pathfinder Cell Therapy,
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators